DIMENSIONAL FUND ADVISORS LP
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 354204
AUSTIN, TX
Position in MRVI
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$4,014,628
+$1,217,851 QoQ
Shares Held
1,418,597
+64.8% QoQ
Ownership
0.549%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 80.71221072651359.ToString("F0")%
Shared 11.453217509976406.ToString("F0")%
None 7.834571763510004.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. MRVI ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in MRVI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,014,628 | 1,418,597 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,796,777 | 860,547 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,687,910 | 936,555 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,271,758 | 942,639 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,775,273 | 1,255,780 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,148,763 | 1,311,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,056,169 | 1,089,792 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,714,120 | 658,397 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,965,978 | 803,458 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $6,030,328 | 920,661 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $11,385,420 | 1,138,542 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $11,524,746 | 927,172 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,270,671 | 376,208 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,293,881 | 369,943 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,632,992 | 338,151 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $9,858,439 | 347,006 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,132,197 | 117,159 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $773,515 | 18,461 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $868,225 | 17,690 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||